Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

This publication has 15 references indexed in Scilit:

• Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy
  Epilepsia, 1996
• Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy
  Life Sciences, 1996
• Topiramate: a potent anticonvulsant in the amygdala-kindled rat
  Epilepsy Research, 1996
• Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures
  Epilepsia, 1996
• Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice
  European Journal of Pharmacology, 1994
• Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant
  Epilepsia, 1994
• Anticonvulsant profile of MDL 27,266: an orally active, broad-spectrum anticonvulsant agent
  Epilepsy Research, 1992
• Modulation of N-methyl-d-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells
  Brain Research, 1991
• Binding of pregnenolone sulfate to rat brain membranes suggests multiple sites of steroid action at the GABAA receptor
  European Journal of Pharmacology: Molecular Pharmacology, 1990
• A Note on a Simple Apparatus for Detecting Neurological Deficit in Rats and Mice**College of Pharmacy, University of Nebraska, Lincoln 8.
  Journal of the American Pharmaceutical Association (Scientific ed.), 1957